Back to search

Article

<i>Quantum CART</i> ( <i>qCART</i> ), a <i>piggyBac-based</i> system for development and production of virus-free multiplex CAR-T cell therapy

2022-05-04

Abstract excerpt

Chimeric antigen receptor T (CAR-T) cell therapy has the potential to transform cancer treatment. However, CAR-T therapy application is currently limited to certain types of relapsed/refractory B cell lymphomas. To unlock the full potential of CAR-T therapy, technologic breakthroughs will be needed in multiple areas, including optimization of autologous CAR-T development, shortening the innovation cycle, and furth...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dbd0102c-9540-5d3b-b507-4a69ee3e5a5d
DOI
10.1101/2022.05.03.490469
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
<i>Quantum CART</i> ( <i>qCART</i> ), a <i>piggyBac-based</i> system for development and production of virus-free multiplex CAR-T cell therapyDOI 10.1101/2022.05.03.490469
Manufacturing CD20/CD19-targeted iCasp9 regulatable CAR-T <sub>SCM</sub> cells using <i>qCART</i> , the <i>Quantum pBac</i> -based CAR-T systemSemantic proximity
Current Non-Viral-Based Strategies to Manufacture CAR-T CellsSemantic proximity
The Past, Present, and Future of Non-Viral CAR T CellsSemantic proximity
Automated, scaled, transposon-based production of CAR T cellsSemantic proximity
Evolution of the clinical-stage hyperactive TcBuster transposase as a platform for robust non-viral production of adoptive cellular therapiesSemantic proximity
Transposon-Based CAR T Cells in Acute Leukemias: Where Are We Going?Semantic proximity
Non-Viral Engineering of CAR-NK and CAR-T cells using the <i>Tc Buster</i> Transposon System™Semantic proximity
Enzymatically produced piggyBac transposon vectors for efficient non-viral manufacturing of CD19-specific CAR T cellsSemantic proximity
Choosing the Right Tool for Genetic Engineering: Clinical Lessons from Chimeric Antigen Receptor-T CellsSemantic proximity
Generation and GMP scale-up of human CAR-T cells using non-viral Sleeping Beauty transposons for B cell malignancesSemantic proximity
CAR T Cell Therapy: A Versatile Living DrugSemantic proximity
Review: Sustainable Clinical Development of CAR-T Cells – Switching From Viral Transduction Towards CRISPR-Cas Gene EditingSemantic proximity
Select a neighboring publication to make it the new centre.